Stay updated on IPI-145 Plus FCR in CLL Clinical Trial

Sign up to get notified when there's something new on the IPI-145 Plus FCR in CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IPI-145 Plus FCR in CLL Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T13:45:37.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page has removed detailed information about a research study on IPI-145 for chronic lymphocytic leukemia, including eligibility criteria and treatment phases, while adding a new version revision and the name of a collaborator.
    Difference
    21%
    Check dated 2025-04-16T01:39:09.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-08T20:12:29.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T15:28:04.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-03-25T13:08:34.000Z thumbnail image
  8. Check
    57 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-03-18T04:58:07.000Z thumbnail image

Stay in the know with updates to IPI-145 Plus FCR in CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IPI-145 Plus FCR in CLL Clinical Trial page.